Pharmacological treatment does not influence endothelial cell identity or cell size but decreases the nuclear size. by Katrin Kalies (13217811)

Investigation of oligomeric size distribution in the proteins. by Aref Baharvand (21713886)

BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

The effect of HA digestion and HA replenishment alone or with CS on barrier function measured by TEER. by Charlotte J. van Ginkel (20790466)

“…PS decreased TEER. (C) Different treatments (treatment groups n = 8)with HA and/or CS did not affect TEER recovery after PS treatment, full recovery was seen in all groups after 24 hours. …”

Statins resulted in smaller neuronal soma size. by Shuk C. Tsoi (21192243)

“…Soma areas of BrdU-/Hu+ neurons, (same data as BrdU-/Hu+ cells shown in A) plotted as means for individual birds, again show smaller sizes in statin-treated birds than in control birds (C). …”

BA attenuated the decrease in the integrity and increase in the permeability of the epithelial barrier injury induced by LPS in Caco2 cell monolayers. by Luqiong Liu (11537092)

“…<p>(<b>A)</b> Changes in TEER with increasing culture time on days 1–22. (<b>B)</b> BA alleviated the LPS-induced decrease in TEER in Caco2 cells after treatment for 24 h. …”

Parameters c and d. by Junxia Zhou (14381598)

Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes. by Md. Akeruzzaman Shaon (21511929)

Y-27632 collaborated with BA to attenuate the increase in the integrity and decrease in the permeability of epithelial barrier injury induced by LPS in Caco2 monolayers. by Luqiong Liu (11537092)

“…(<b>C</b>) Y-27632 collaborated with BA to alleviate the decrease in FD-4 flux in LPS-induced Caco2 cells on day 22. …”

Y-27632 synergized with BA to alleviate the decrease in the expression of and abnormal localization of ZO-1 and Occludin in LPS-induced Caco2 cells. by Luqiong Liu (11537092)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

Schematic diagram of experimental injector size. by Lei Bai (631944)

Subjects:

<i>trusRNAi</i> induced with various wing disc drivers affects wing size and morphology and decreases cellular proliferation. by Saeko Takada (21616085)

Extensive loading of WPB with the synthetic MaPCa Ca²⁺-Indicators affects WPB size. by Julian Terglane (12975565)

Particle size distribution before and after desiliconization of mixed ore by Nian Liu (29935)

Expression of ClC-1. by Rie Asayama (693361)

Fiber size and the VC. by Rie Asayama (693361)

Relationship between effect size, coverage, sample size, and power. by Amy Longtin (21409957)

Image 1_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

“…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”

Table 1_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.docx by Francesca Bietto (21511316)

“…</p>Results<p>Our research demonstrates that GDC decreases Caco-2/HT29-MTX Trans-Epithelial Electrical Resistance (TEER) and increases paracellular permeability, without inflammation or cytotoxicity. …”